ArticleTranslational pediatrics2025
Predicting death and survival without major morbidity for extremely preterm infants using information on hospital admission: a multicenter cohort study.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Survival without major morbidity in extremely preterm infants: a prospective multicenter study in Shenzhen, China.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate prediction of outcomes for extremely preterm infants (EPIs) during the early stage is important to assist clinicians and parents in making decisions. This study aimed to develop and validate models for predicting mortality and survival without major morbidity for EPIs using information available on neonatal intensive care units (NICUs) admission. Methods: Two of the largest contemporary cohorts of EPIs born at 24 Results: Among 2,438 EPIs in the development cohort, the mortality rate was 17.7% (431/2,438) and the rate of survival without major morbidity was 52.5% (1,281/2,438). Among the 5,045 infants in the validation cohort, 9.2% (463/5,045) died, and 59.1% (2,981/5,045) survived without major morbidity. Gestational age, birth weight, invasive ventilation on NICU admission, antenatal steroids use, and 5-min Apgar score were selected as predictors in the mortality model, yielding the AUC of 0.77 [95% confidence interval (CI): 0.75-0.79]. For the survival without major morbidity model, predictors were gestational age, birth weight, invasive ventilation on NICU admission, sex, and 5-min Apgar score, and the AUC was 0.72 (95% CI: 0.70-0.74). The validation cohort resulted in AUCs of 0.76 (95% CI: 0.73-0.78) and 0.70 (95% CI: 0.68-0.71) for the mortality and survival without major morbidity models, respectively. Conclusions: Using commonly available predictors on NICU admission including gestational age, birth weight, invasive ventilation on NICU admission, antenatal steroids use, sex, and 5-min Apgar score, we successfully developed and validated two distinct models with acceptable performance, predicting mortality and survival without major morbidity for EPIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.